伊斯特拉德菲林对震主导 (TD) 和姿势不稳定性和步行困难 (PIGD) 的影响
Yasar Torres-Yaghi1, Nobutaka Hattori2, Olivier Rascol3
1Department of Neurology, Georgetown University Hospital, Washington, DC, USA.
Clinical parkinsonism & related disorders
|November 29, 2023
概括
伊斯特拉德菲林改善了帕金森病 (PD) 患者的运动残疾,这些患者有运动波动. 这种选择性腺A2A受体对手在震主导和姿势不稳定/走路困难亚型中显示出好处.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 呈现出不同的运动亚型:震主导 (TD) 和姿势不稳定和步行困难 (PIGD).
- 这些亚型可以通过统一帕金森病评分表 (UPDRS) 的子分数进行区分.
- 伊斯特拉德菲林是一种选择性腺A2A受体对抗剂,用于PD治疗.
研究的目的:
- 为了检查伊斯特拉德菲林对帕金森病患者的TD和PIGD运动亚型的影响.
- 分析关键临床试验的综合数据,以评估特定亚型的治疗反应.
主要方法:
- 来自8个随机,安慰剂控制的2b/3期试验的汇总数据的后期分析.
- 发生运动并发症的Levodopa治疗患者接受了伊斯特拉德菲林 (每天20或40毫克) 或安慰剂.
- 发动机子类型 (TD,PIGD,混合型) 根据UPDRS II/III项目得分比率进行定义.
主要成果:
- 总共有2719名患者被纳入分析.
- 与安慰剂相比,伊斯特拉德菲林 (20 mg/天) 在TD亚型患者中显著改善了UPDRS II/IIITD相关得分.
- 与安慰剂相比,伊斯特拉德菲林 (40 mg/天) 在PIGD亚型患者中显著改善了与UPDRS II/III PIGD相关的得分.
结论:
- 伊斯特拉德菲林在改善帕金森病患者的运动残疾方面表现出有效性,无论其运动亚型如何,都具有运动波动.
- 需要进一步的研究,以充分描述伊斯特拉德菲林对PD患者震的影响.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
401
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
401
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
342
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
342
Sedatives and Hypnotics Drugs: Miscellaneous Agents
179
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
179
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248


